Healthcare

Comms outreach efforts pass the test for Interpace

Comms outreach efforts pass the test for Interpace

A combination of traditional and modern comms tactics help molecular diagnostic testing company Interpace craft messages that resonate with all key audiences.

How women can empower themselves to close biopharma's gender pay gap

How women can empower themselves to close biopharma's gender pay gap

By

Women healthcare leaders discussed the gender pay gap and tools for women to advocate for themselves on stage at MM&M's Hall of Femme event Thursday.

AARP, tech firms to test voice-based health tools among senior set

AARP, tech firms to test voice-based health tools among senior set

By

Pillo's voice-activated robot will be studied among those 50-plus with diabetes. The robot uses facial recognition and can respond HIPAA-compliantly to questions.

A tale of two headlines leads to breast cancer confusion

A tale of two headlines leads to breast cancer confusion

Healthcare journalists and communicators have an obligation to facilitate informed conversation, not simply put out information. Does the Times' take on a recent gene test live up to that standard?

We asked for your take on pharma's diversity push. Here are the responses

We asked for your take on pharma's diversity push. Here are the responses

MM&M asked the pharma marketing community at large, via social media and other efforts, to provide its POV on equality, diversity, and inclusion.

Five things for pharma marketers to know: Monday, June 4, 2018

Five things for pharma marketers to know: Monday, June 4, 2018

By

New study finds early-stage breast cancer may not need chemo; Merck's Keytruda succeeds in more studies; Athenahealth CEO faces allegations of inappropriate behavior

Transparency may have taken a back seat on this diversity drive

Transparency may have taken a back seat on this diversity drive

By

MM&M/Publicis Health's first Diversity Survey reveals some notable shifts to making the healthcare industry more inclusive, yet many agencies didn't feel like opening up about their diversity numbers.

AstraZeneca reprimanded by UK drug regulator for 'misleading' press release

AstraZeneca reprimanded by UK drug regulator for 'misleading' press release

By

A UK drug regulator has ruled that a 2017 press release from AstraZeneca was "misleading" as data "had not been presented in a balanced way", following a complaint from a fellow pharma firm.

Marijuana: a green grey zone for patients, doctors, and pharma companies

Marijuana: a green grey zone for patients, doctors, and pharma companies

By

Legalization of the drug for medical use is already having an impact on prescription patterns. But for patients and doctors alike, there are a lot of unanswered questions.

How drugmakers are facing the entrance of consumer giants into healthcare

How drugmakers are facing the entrance of consumer giants into healthcare

By

As deepening healthcare forays by tech and e-commerce giants ratchet up the pressure on pharma to become more consumer friendly, drugmakers are still defining their new role.

MM&M Hall of Femme 2018: The profiles

MM&M Hall of Femme 2018: The profiles

MM&M is honoring 15 of the most-senior women in healthcare along with 20 Women to Watch who are changing the industry.

Alisa Lask, Galderma

Alisa Lask, Galderma

Alisa Lask is VP and GM, U.S. aesthetic business unit of Galderma, Nestlé Skin Health.

Neera Chaudhary, Golin

Neera Chaudhary, Golin

Neera Chaudhary is global president of healthcare of Golin.

Wendy Blackburn, Intouch Solutions

Wendy Blackburn, Intouch Solutions

Wendy Blackburn is EVP, marketing and communications of Intouch Solutions.

Wendy Lund, GCI Health

Wendy Lund, GCI Health

Wendy Lund is CEO of GCI Health.

Vanessa Thirion-Cullity, Novartis Oncology

Vanessa Thirion-Cullity, Novartis Oncology

Vanessa Thirion-Cullity is executive director, U.S. NET of Novartis Oncology.

Meet the 2018 Women to Watch Honorees

Meet the 2018 Women to Watch Honorees

MM&M is honoring 20 Women to Watch, aspiring healthcare commercial and marketing execs changing the face of the industry.

Former FDA commissioner Califf to pharma: opening up on health data requires overcoming risk

Former FDA commissioner Califf to pharma: opening up on health data requires overcoming risk

By

Califf spoke about the importance of more data to faster and cheaper drug development at the NewYorkBIO conference.

Whither the pharma Grand Prix? Questions abound in run-up to Cannes health fest

Whither the pharma Grand Prix? Questions abound in run-up to Cannes health fest

Whether jurors will award a pharma Grand Prix, and whether US pharma will show up, are two open questions in the run-up to Lions Health.

'Not a good day for Novartis': how the Novartis-Cohen crisis unfolded

'Not a good day for Novartis': how the Novartis-Cohen crisis unfolded

By

Here's a recap of the Novartis-Michael Cohen crisis, which unfolded this week, including how the drugmaker has responded to scrutiny over its $1.2 million contract with Cohen's firm.

Evidence-based patient access programs

Evidence-based patient access programs

By

At the Asembia Specialty Pharma summit, speakers described a healthcare ecosystem in which specialty products will represent nearly half of all drug spending.

Interview | Paul LeVine, TrialCard

Interview | Paul LeVine, TrialCard

By

Paul LeVine, VP, Analytic Services for TrialCard, describes proven strategies that prevent patient adherence fall off, driven by evidenced-based design and patient engagement programs.

GSK reviews $1.76 billion global media

GSK reviews $1.76 billion global media

By

Pharma giant GlaxoSmithKline has reportedly launched a review of its $1.76 billion global media agency arrangements, putting MediaCom and PHD on alert.

Trust in health sector takes a hit in major markets, Edelman research finds

Trust in health sector takes a hit in major markets, Edelman research finds

By

The healthcare sector has suffered a dip in public trust in major markets including France, India and the US, but Britons remain among the more trusting globally, according to the Edelman Health Trust Barometer.

Interview | Gary Scheiner, GHG

Interview | Gary Scheiner, GHG

By

Gary Scheiner, EVP and chief creative officer at GHG, discusses the inherent tension in day-to-day marketing for healthcare brands.

Merck's Gerberding, Publicis Health's Colucci call for courage in tackling gender parity

Merck's Gerberding, Publicis Health's Colucci call for courage in tackling gender parity

By

Both leaders were honored at Healthcare Businesswomen's Association 2018 Woman of the Year event in New York.

How pharma and healthcare shifted strategies post-blockbuster drug success

How pharma and healthcare shifted strategies post-blockbuster drug success

Remedy Health Media's Mike Collins discusses ways pharma and healthcare companies have shifted their strategies in the years after the success of blockbuster drugs.

Drugs' value to patients eclipsed by price tags

Drugs' value to patients eclipsed by price tags

Like other sectors, pharma is experiencing upheavals no one predicted, and as a result, drugs are being reviled for their price tags, rather than praised for their value.

Agencies enable staff to find well-being through work

Agencies enable staff to find well-being through work

By

Anatomy of Agency Culture is a supplement designed not only to showcase internal programs, but to examine them with an eye on how they impact company culture.

4 agencies making a difference in their communities and around the world

4 agencies making a difference in their communities and around the world

By

Four agencies are making a difference by supporting nonprofits, educating and empowering youth, and promoting wellness and sustainability in communities around the world